Generally Accepted Accounting Principles

Martek confirms solid 2004

Martek confirms solid 2004

Martek Biosciences last week announced its year-end results, noting
increased revenues and "robust growth" due primarily to higher
sales of nutritional products to the company's infant formula
licensees.

Weider reports 1Q results

Weider reports 1Q results

US marketer of private label vitamins saw sales drop in its 2003
first quarter, due to the sale of two brands in July this year.
However gross profit and operating income was up on the same period
last year.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers